JOE DI SALVO

Chief Strategy Officer

For more than two decades, Joe Di Salvo has been an advisor, counselor, and trusted partner to many iconic brands that have transformed key segments of the retail marketplace.  He is the founder and managing partner of Di Salvo Howard PLLC, a boutique law practice that primarily works with private equity backed small- and middle-market branded consumer products in a variety of categories, including food, beverage, supplements, and personal care. As managing partner of the firm, Joe works closely with investors, founders, management teams, and boards to accelerate growth and maximize enterprise value.  

 

Joe provides strategic, insightful, practical advice and guidance concerning the critical functions of his clients’ businesses, including corporate governance, finance, operations, marketing, sales, intellectual property, human resources, and dispute resolution. Current and former clients include KIND® Snacks, Drunk Elephant®, Sun Bum®, Perfect Snacks®, Pirate’s Booty®, Pretzel Crisps®, Bare Foods®, Spindrift®, Vega®, Lily’s®, Ancient Nutrition®, Daily Harvest®, Justin’s®, The Honey Pot Company®, Briogeo®, and babyganics®, among others. Joe also serves on the advisory boards for Red Pine Capital Partners, LLC and MedPower, LLC.

 

Prior to forming Di Salvo Howard, Joe was vice president and general counsel for Glaceau, Inc., maker of vitaminwater® and smartwater®, where he played an integral role in the development and execution of the company’s growth and exit strategy to the Coca-Cola Company in 2007 for $4.1b. Joe began his career as a trial attorney with the law firm of McCarter & English, LLP, where he was a founding member of the firm's New York Office.

 

For the past six years, Joe has served as an adjunct professor at the NYU Stern School of Business, where he teaches Professional Responsibility & Leadership.  Joe is also the director and producer of the documentary film Bronx Socrates, which is presently in post production, and slated for worldwide distribution in 2025.